2019年11月美国全国电子烟或雾化产品使用相关肺损伤暴发中住院与非住院患者的特征
截至2019年11月13日,美国49州、哥伦比亚特区及两个领地报告2172例电子烟或雾化产品使用相关肺损伤(EVALI)病例,包括42例(1.9%)死亡。对截至2019年11月5日收集的2016例有住院状态数据的患者分析显示,1906例(95%)住院,110例(5%)未住院;两组人口学特征及含四氢大麻酚(THC)产品使用比例相似。鉴于类似性及流感季鉴别困难,CDC将不再收集全国非住院EVALI患者数据。
要点
- 2016例EVALI患者中95%住院,5%未住院,两组人口学及THC产品使用相似。
- CDC将不再收集全国非住院EVALI患者数据,改由各州酌情收集。
- 门诊管理候选者需氧饱和度正常(室内空气下≥95%)且无呼吸窘迫等条件。
核心结论
- 住院与非住院EVALI患者特征相似,结合流感季呼吸道感染可能增多及鉴别困难,CDC将不再收集全国非住院EVALI患者数据。
研究设计与样本
- 分析各州向CDC报告的住院与非住院EVALI患者病例报告信息,数据截至2019年11月5日。
主要发现
- 截至2019年11月13日,49州、哥伦比亚特区及两个领地报告2172例EVALI病例,包括42例(1.9%)EVALI相关死亡。
- 2016例有住院状态数据的患者中,1906例(95%)住院,110例(5%)未住院。
- 住院患者中男性占68%,非住院患者中男性占65%;住院患者中年龄<35岁占78%,非住院患者中占74%。
- 住院患者中使用含THC产品占83%,非住院患者中占84%。
关键数值与推荐
- 门诊管理EVALI候选者应具备:室内空气下氧饱和度≥95%、无呼吸窘迫、无可能损害肺储备的合并症、可靠就医途径、强大社会支持系统,并能确保初次评估后24-48小时内随访及呼吸症状加重时及时就医。
临床怎么用
- CDC将不再收集全国非住院EVALI患者数据,进一步收集由各州、地方和领地卫生部门酌情决定。
- 医疗服务提供者应强调所有≥6个月人群每年接种流感疫苗的重要性,包括使用电子烟或雾化产品者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CDC, the Food and Drug Administration (FDA), state and local health departments, and public health and clinical stakeholders are investigating a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) (1). As of November 13, 2019, 49 states, the District of Columbia, and two U.S. territories (Puerto Rico and U.S. Virgin Islands) have reported 2,172 EVALI cases to CDC, including 42 (1.9%) EVALI-associated deaths. To inform EVALI surveillance, including during the 2019-20 influenza season, case report information supplied by states for hospitalized and nonhospitalized patients with EVALI were analyzed using data collected as of November 5, 2019. Among 2,016 EVALI patients with available data on hospitalization status, 1,906 (95%) were hospitalized, and 110 (5%) were not hospitalized. Demographic characteristics of hospitalized and nonhospitalized patients were similar; most were male (68% of hospitalized versus 65% of nonhospitalized patients), and most were aged <35 years (78% of hospitalized versus 74% of nonhospitalized patients). These patients also reported similar use of tetrahydrocannabinol (THC)-containing products (83% of hospitalized versus 84% of nonhospitalized patients). Given the similarity between hospitalized and nonhospitalized EVALI patients, the potential for large numbers of respiratory infections during the emerging 2019-20 influenza season, and the potential difficulty in distinguishing EVALI from respiratory infections, CDC will no longer collect national data on nonhospitalized EVALI patients. Further collection of data on nonhospitalized patients will be at the discretion of individual state, local, and territorial health departments. Candidates for outpatient management of EVALI should have normal oxygen saturation (≥95% while breathing room air), no respiratory distress, no comorbidities that might compromise pulmonary reserve, reliable access to care, strong social support systems, and should be able to ensure follow-up within 24-48 hours of initial evaluation and to seek medical care promptly if respiratory symptoms worsen. Health care providers should emphasize the importance of annual influenza vaccination for all persons aged ≥6 months, including persons who use e-cigarette, or vaping, products (2,3).
引用
- Chatham-Stephens K, Roguski K, Jang Y, et al. Characteristics of Hospitalized and Nonhospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, November 2019. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31751326. doi:10.15585/mmwr.mm6846e1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。